Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

IL-6: The Link Between Inflammation, Immunity and Breast Cancer
Juan Chen, Yanghui Wei, Weiqin Yang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 72

Showing 1-25 of 72 citing articles:

Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment
Ola Habanjar, Rea Bingula, Caroline Decombat, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4002-4002
Open Access | Times Cited: 109
A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments
Salma M. Hefny, Tarek F. El‐Moselhy, Nabaweya Sharaf El-Din, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116527-116527
Closed Access | Times Cited: 12
Patient-Specific Vascularized Tumor Model: Blocking TAM Recruitment with Multispecific Antibodies Targeting CCR2 and CSF-1R
Huu Tuan Nguyen, Ellen L. Kan, Mouhita Humayun, et al.
Biomaterials (2024) Vol. 312, pp. 122731-122731
Open Access | Times Cited: 9
Functional role of skeletal muscle-derived interleukin-6 and its effects on lipid metabolism
Weimin Lin, Hongbin Song, Jieqiong Shen, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 17
Rationale design of novel substituted 1,3,5-triazine candidates as dual IDH1(R132H)/ IDH2(R140Q) inhibitors with high selectivity against acute myeloid leukemia: In vitro and in vivo preclinical investigations
Haytham O. Tawfik, Mai H. A. Mousa, Mohamed Y. Zaky, et al.
Bioorganic Chemistry (2024) Vol. 149, pp. 107483-107483
Closed Access | Times Cited: 7
Gold Nanoparticles Downregulate IL-6 Expression/Production by Upregulating microRNA-26a-5p and Deactivating the RelA and NF-κBp50 Transcription Pathways in Activated Breast Cancer Cells
Aisha Farhana, Abdullah Alsrhani, Ruqaih S. Alghsham, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1404-1404
Open Access | Times Cited: 5
Extracellular Vesicles in Breast Cancer: From Intercellular Communication to Therapeutic Opportunities
Muttiah Barathan, Sook Luan Ng, Yogeswaran Lokanathan, et al.
Pharmaceutics (2024) Vol. 16, Iss. 5, pp. 654-654
Open Access | Times Cited: 5
Age, cancer, and the dual burden of cancer and doxorubicin in skeletal muscle wasting in female rats: which one to blame?
Alexandra Moreira‐Pais, Rita Ferreira, Inês Aires, et al.
Biogerontology (2025) Vol. 26, Iss. 1
Closed Access
IL‐6 mediated CD206+ARG‐1+ tumor associated macrophage polarization induces Treg infiltration in non‐responder luminal A breast cancer
Ananya Das, Sraddhya Roy, Aparajita Bairagi, et al.
FEBS Letters (2025)
Closed Access
The prediction power of thymidine phosphorylase and IL-6 in the relapse of breast cancer
Ahmed Hussein Zwamel, Hind M. Mousa, Bushra A. M. Abdul Azeez, et al.
Polski Merkuriusz Lekarski (2025) Vol. 53, Iss. 1, pp. 88-93
Closed Access
The effect of breast cancer surgery on inflammatory response: important role of interleukin-6 and platelet-to-lymphocyte ratio in breast cancer surgery
Gani Dwi Cahya, Mohamad Sofyan Harahap, Banundari Rachmawati, et al.
Deleted Journal (2025) Vol. 18, Iss. 1, pp. 47-61
Closed Access
The current advances of lncRNAs in breast cancer immunobiology research
Marco Antonio Fonseca-Montaño, Karla Itzel Vázquez-Santillán, Alfredo Hidalgo‐Miranda
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Chronic exposure to low-dose MC-LR induces ileal inflammation in mice through the PI3K/AKT/mTOR pathway
Mingjie Yang, Shuilin Zheng, Wen Zeng, et al.
Journal of Toxicology and Environmental Health (2025), pp. 1-9
Closed Access
Potential applications of gene expression profiles obtained from circulating extracellular vesicles in breast cancer.
Aritra Gupta, Siddharth Bhardwaj, Sayan Ghorai, et al.
The Journal of Liquid Biopsy (2025) Vol. 7, pp. 100287-100287
Open Access
Knowledge of the genetics of human pain gained over the last decade from next-generation sequencing
Dario Kringel, Jörn Lötsch
Pharmacological Research (2025), pp. 107667-107667
Open Access
A standardized chamuangone enriched extract shows anticancer efficacy in allograft models of metastatic breast cancer
Asad Ur Rahman, Naveed Ullah Khan, Pharkphoom Panichayupakaranant, et al.
Journal of Functional Foods (2025) Vol. 127, pp. 106730-106730
Closed Access
GOReverseLookup: A gene ontology reverse lookup tool
Aljoša Škorjanc, Vladimir Smrkolj, Nejc Umek
Computers in Biology and Medicine (2025) Vol. 191, pp. 110185-110185
Open Access
Insights into the Relationship between Pentraxin-3 and Cancer
Mária Bogdán, Andreea-Daniela Meca, Adina Turcu-Ştiolică, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15302-15302
Open Access | Times Cited: 17
Synthesis and Biological Evaluation of Potential Oncoimmunomodulator Agents
Raquel Gil-Edo, Sara Espejo, Eva Falomir, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2614-2614
Open Access | Times Cited: 9
Phytochemical Composition and Antioxidant and Anti-Inflammatory Activities of Humboldtia sanjappae Sasidh. & Sujanapal, an Endemic Medicinal Plant to the Western Ghats
Jameema Sidhic, Satheesh George, Ahmed Alfarhan, et al.
Molecules (2023) Vol. 28, Iss. 19, pp. 6875-6875
Open Access | Times Cited: 9
MCT4 Knockdown by Tumor Microenvironment-Responsive Nanoparticles Remodels the Cytokine Profile and Eradicates Aggressive Breast Cancer Cells
Ahmed A. H. Abdellatif, Abdellatif Bouazzaoui, Hesham M. Tawfeek, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 238, pp. 113930-113930
Closed Access | Times Cited: 3
CD44v5 domain regulates crosstalk between TNBC cells and tumor‐associated macrophages by enhancing the IL‐4R/STAT3 axis
Yanhua Dai, Zhongjian Ji, Hongyan Liang, et al.
Cancer Science (2024) Vol. 115, Iss. 7, pp. 2235-2253
Open Access | Times Cited: 3
MiR-449a antagonizes EMT through IL-6-mediated trans-signaling in laryngeal squamous cancer
Alessia Maria Cossu, Federica Melisi, Teresa Noviello, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 1, pp. 102140-102140
Open Access | Times Cited: 2
A new copper(II) complex containing long-chain aliphatic hydrazide and 1,10-phenanthroline upregulates ADP hydrolysis in triple-negative breast cancer cells
Helen Soares Valença Ferreira, Luana Munique Sousa Ramos, Fernanda Cardoso da Silva, et al.
Journal of Inorganic Biochemistry (2024) Vol. 255, pp. 112524-112524
Closed Access | Times Cited: 2
Potential Role of Circulating PD-L1+ Leukocytes as a Predictor of Response to Anti-PD-(L)1 Therapy in NSCLC Patients
Geòrgia Anguera, Maria Mulet, Carlos Zamora, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 958-958
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top